Wang JQ - Search Results

1

Yang B, Wang JQ, Tan Y, Yuan R, Chen ZS, Zou C. Yang B, et al. Among authors: wang jq. Pharmacol Res. 2021 Dec;174:105937. doi: 10.1016/j.phrs.2021.105937. Epub 2021 Oct 12. Pharmacol Res. 2021. PMID: 34648969 Free article. Review.

2

Discovery of 5-Cyano-6-phenylpyrimidin Derivatives Containing an Acylurea Moiety as Orally Bioavailable Reversal Agents against P-Glycoprotein-Mediated Mutidrug Resistance.

Wang B, Ma LY, Wang JQ, Lei ZN, Gupta P, Zhao YD, Li ZH, Liu Y, Zhang XH, Li YN, Zhao B, Chen ZS, Liu HM. Wang B, et al. Among authors: wang jq. J Med Chem. 2018 Jul 26;61(14):5988-6001. doi: 10.1021/acs.jmedchem.8b00335. Epub 2018 Jul 18. J Med Chem. 2018. PMID: 29975529

3

Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells.

Ji N, Yang Y, Cai CY, Lei ZN, Wang JQ, Gupta P, Shukla S, Ambudkar SV, Kong D, Chen ZS. Ji N, et al. Among authors: wang jq. Cancer Lett. 2019 Jan;440-441:82-93. doi: 10.1016/j.canlet.2018.10.007. Epub 2018 Oct 10. Cancer Lett. 2019. PMID: 30315846 Free PMC article.

4

Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells.

Zhang W, Fan YF, Cai CY, Wang JQ, Teng QX, Lei ZN, Zeng L, Gupta P, Chen ZS. Zhang W, et al. Among authors: wang jq. Front Pharmacol. 2018 Oct 9;9:1097. doi: 10.3389/fphar.2018.01097. eCollection 2018. Front Pharmacol. 2018. PMID: 30356705 Free PMC article.

5

VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters.

Ji N, Yang Y, Cai CY, Lei ZN, Wang JQ, Gupta P, Teng QX, Chen ZS, Kong D, Yang DH. Ji N, et al. Among authors: wang jq. Front Pharmacol. 2018 Oct 30;9:1236. doi: 10.3389/fphar.2018.01236. eCollection 2018. Front Pharmacol. 2018. PMID: 30425643 Free PMC article.

6

Ulixertinib (BVD-523) antagonizes ABCB1- and ABCG2-mediated chemotherapeutic drug resistance.

Ji N, Yang Y, Lei ZN, Cai CY, Wang JQ, Gupta P, Xian X, Yang DH, Kong D, Chen ZS. Ji N, et al. Among authors: wang jq. Biochem Pharmacol. 2018 Dec;158:274-285. doi: 10.1016/j.bcp.2018.10.028. Epub 2018 Oct 26. Biochem Pharmacol. 2018. PMID: 30431011

7

Modulating ROS to overcome multidrug resistance in cancer.

Cui Q, Wang JQ, Assaraf YG, Ren L, Gupta P, Wei L, Ashby CR Jr, Yang DH, Chen ZS. Cui Q, et al. Among authors: wang jq. Drug Resist Updat. 2018 Nov;41:1-25. doi: 10.1016/j.drup.2018.11.001. Epub 2018 Nov 14. Drug Resist Updat. 2018. PMID: 30471641 Review.

8

Gaseous signaling molecules and their application in resistant cancer treatment: from invisible to visible.

Cui Q, Yang Y, Ji N, Wang JQ, Ren L, Yang DH, Chen ZS. Cui Q, et al. Among authors: wang jq. Future Med Chem. 2019 Feb;11(4):323-336. doi: 10.4155/fmc-2018-0403. Epub 2019 Feb 25. Future Med Chem. 2019. PMID: 30802141 Review.

9

Tepotinib reverses ABCB1-mediated multidrug resistance in cancer cells.

Wu ZX, Teng QX, Cai CY, Wang JQ, Lei ZN, Yang Y, Fan YF, Zhang JY, Li J, Chen ZS. Wu ZX, et al. Among authors: wang jq. Biochem Pharmacol. 2019 Aug;166:120-127. doi: 10.1016/j.bcp.2019.05.015. Epub 2019 May 9. Biochem Pharmacol. 2019. PMID: 31078601

10

Midostaurin Reverses ABCB1-Mediated Multidrug Resistance, an in vitro Study.

Ji N, Yang Y, Cai CY, Wang JQ, Lei ZN, Wu ZX, Cui Q, Yang DH, Chen ZS, Kong D. Ji N, et al. Among authors: wang jq. Front Oncol. 2019 Jun 18;9:514. doi: 10.3389/fonc.2019.00514. eCollection 2019. Front Oncol. 2019. PMID: 31275850 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,494 results

Search Page

Filters